O2 RegenTech awarded $100,000 from Innovation Fund Northeast Ohio

Story excerpt provided by Crain’s Cleveland Business.

O2 RegenTech, a medical device startup out of the University of Akron, has received a boost with $100,000 in funding from the Innovation Fund Northeast Ohio, according to the university.

Founded in 2013 by Nic Leipzig, an associate professor in chemical and biomolecular engineering, O2 RegenTech specializes in wound-care solutions based on technology developed by Leipzig. Andreas Inmann, O2 RegenTech’s president and CEO, helped Leipzig commercialize his work. The company’s primary product, OXAID, is an oxygen-releasing, antimicrobial dressing for the treatment of chronic wounds.

Click here to read the complete article.

Originally published June 27, 2017.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: